Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial.

"Disclosures None."

"Sources of Funding This trial was sponsored by King’s College London and funded by the National Institute for Health and Care Research Health Technology Assessment Program (10/57/67). The arrhythmia analyses were supported by the British Heart Foundation (fellowship FS/CRTF/21/24190 and the King’s British Heart Foundation Center of Research Excellence grant RE/18/2/34213)."

"REVIVED was a prospective, multicenter, randomized, open-label trial involving 700 patients with ILVD; randomization was to either PCI+OMT or OMT alone. Participants were enrolled between 2013 and 2020; full patient eligibility criteria have been published previously. The trial protocol was registered before the enrollment of the first patient (https://www.clinicaltrials.gov; NCT01920048) and was approved by the UK Health Research Authority. All patients provided written informed consent. The data that support the findings of this study and the analytic methods will be made available 1 year from the completion of the trial on reasonable request to the corresponding author. REGISTRATION:: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01920048."